logo
‘Popcorn Lung': Making a Historically Difficult Diagnosis

‘Popcorn Lung': Making a Historically Difficult Diagnosis

Medscape18-06-2025
Among the many things that the Industrial Revolution gave rise to was the potential for more rapid spread of public health crises. Communicable diseases such as cholera, typhus, and tuberculosis all spiked during this era due to urbanized living, increased mass communication, and still-evolving sanitation safety measures. The early 20th century also marked increased prevalence of occupational respiratory illnesses, such as silicosis, chronic obstructive pulmonary disease (COPD), and a newly-identified condition — bronchiolitis obliterans — that in many ways has puzzled healthcare professionals ever since.
First diagnosed in 1901 among healthy factory workers who were exposed to nitrogen dioxide, this fibrosing obstructive lung disease has earned the moniker 'popcorn lung' because of its connection to an outbreak at a factory 25 years ago. That outbreak in Jasper, Missouri, was among workers who inhaled diacetyl, a synthetic flavoring agent for microwavable popcorn. Although the disease can also be caused by other harmful food production exposures.
Characterized by a dry cough, shortness of breath, wheezing, and inflammation that results in partial or complete obliteration of the lung's smallest airways and irreversible scaring, the disease continues to be difficult to diagnose. The disease also is more challenging to care for the longer it goes undetected.
While it frequently develops in patients who undergo lung transplant and is associated with rheumatic conditions and various respiratory infections, bronchiolitis obliterans is rare and can masquerade as other common pulmonary diseases when symptoms aren't properly recognized.
Difficult Diagnosis
In August 2000, employees at Gilster-Mary Lee Corporation, a food manufacturing and distribution company, experienced a similar set of respiratory issues, including cold-like symptoms that didn't improve with medication. The National Institute for Occupational Safety and Health (NIOSH) and the Missouri Department of Health and Senior Services launched an investigation.
'There was this clustering of workers who had developed severe obstructive airway disease and were initially being variously diagnosed with conditions such as emphysema, but, for the most part, they were never smokers,' explained Cecile S. Rose, MD, MPH, a board-certified pulmonology and occupational medicine physician at National Jewish Health, Denver. 'The NIOSH began looking at the workers' epidemiologically and sampling the air. They found that this exposure to diacetyl-containing butter flavoring was the cause. And that's when we began to realize that these types of chemicals, even though they had been stored in very large vats that had lids and were recognized as safe for ingestion, were never safe to be inhaled in large quantities.'
The most likely symptoms of 'popcorn lung' are a persistent cough, plus or minus wheezing, and shortness of breath that worsens with physical exertion — none of which are particularly distinctive. 'The typical symptoms are very nonspecific and are not temporally linked to exposure,' said Rose. 'They are insidious. They creep up. And the symptoms don't help you very much in terms of linking the exposure to the risk of lung disease or its symptoms. But sometimes patients will describe upper airway irritation symptoms, such as sore throat, or eye burning.'
But there are additional symptoms that can complicate diagnosis.
According to Jim Mendez, PhD, CRNP, ANP-BC, clinical associate professor and adult primary care nurse practitioner in the M. Louise Fitzpatrick College of Nursing at Villanova University, Villanova, Pennsylvania, the full spectrum of signs can also include fatigue and chest discomfort. Another troubling indication can be when wheezing is present and does not respond to standard asthma medications, Mendez said.
Eric Costanzo, DO, director of Medical Intensive Care and director of the Pulmonary and Critical Care Fellowship Program at Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune City, New Jersey, said that patients will also often experience nonspecific symptoms that can resemble conditions such as asthma or COPD, including exertional dyspnea and low-grade fever. Weight loss may also be seen, he said.
'But the pathology itself can happen for a number of different reasons, just by virtue of the fact that the lungs have only a few ways to respond to injury — and this injury pattern of bronchiolitis obliterans is one of those ways,' said Amy Hajari Case, MD, chief medical officer of the Pulmonary Fibrosis Foundation and director of the Pulmonary Fibrosis Care Center at Piedmont Healthcare in Atlanta. 'There is inflammation and obliteration of the bronchioles, and it's a situation where the inflammation creates airflow obstruction on the smallest level that sets up a clinical picture that we can now recognize.'
Functional Testing Can Speed Diagnosis
Before a diagnosis can be confirmed, pulmonary function tests are essential to help detect the restricted airflow typical of the condition, suggests Shawn George, DO, an internal medicine physician at Yorktown Health, Vernon Hills, Illinois. 'A computed tomography scan can show damage to the airways, but a biopsy might be needed to confirm the diagnosis.'
The disease is more common among patients who undergo bone marrow or lung transplants, a form of chronic allograft rejection, referred to as defined as 'bronchiolitis obliterans syndrome.'
According to research conducted by the Cleveland Clinic, approximately 50% of patients who undergo lung transplants will develop bronchiolitis obliterans syndrome within 5 years of surgery while approximately 10% of marrow recipients will develop bronchiolitis obliterans syndrome within 5 years.
'Patients can have this type of lung injury related to some of the transplant immunology that occurs,' said Case. 'It can also happen because of certain types of viral or bacterial infections that set up a more acute situation.' These include respiratory syncytial virus and measles, particularly in children.
According to Costanzo, rheumatoid arthritis, systemic lupus erythematosus, and inflammatory bowel disease-related lung disease can also be triggers. 'Histologically they differ from other lung diseases characterized by concentric fibrosis of the bronchioles and eventual obliteration of the airway lumen,' said Costanzo.
Treatment Approaches and Suggestions
Quality of life and disease management can be difficult for patients, said Case. 'There isn't a well-defined standard of care practice for how to help people improve their lung function and there isn't extensive data to guide management in this condition. The first thing to do is to halt any culprit exposure to immediately keep the patient from having continued lung damage.'
Assuming that can be accomplished, there are a range of over-the-counter and prescription options that Case and other physicians are willing to try for their patients. 'Cough suppressants and inhaled bronchodilators are used for symptom management, as well as oxygen therapy if the patient is hypoxemic,' said Case.
'Pulmonary rehabilitation is also utilized for its various benefits, and other treatments such as macrolide antibiotics, systemic steroids, and immunosuppression are tried on an individual basis. But this is a condition that in many cases doesn't respond well to the things that we do. And so patients do not get that same relief as other patients for which we do have a lot of tools and a lot of evidence for using them, even if that condition is not going to go away, such as COPD.'
When it comes to syndrome patients, treatments might also include extracorporeal photopheresis and total lung irradiation. In the worst of all types of cases, patients will require lung transplant. 'One percent of transplants are listed as being for bronchiolitis obliterans for all different etiologies,' said Case.
Vagaries of Vaping
Another potential cause of bronchiolitis obliterans, but for which more substantial evidence is needed, is use of a vape to inhale nicotine-based chemicals, including those that contain diacetyl. Prior to the COVID-19 pandemic, a rash of e-cigarette or vaping-associated lung injury (EVALI) cases had been seen in hospitals across the country.
According to CDC data, more than 2800 hospitalizations and nearly 70 US deaths reported as of February 2020 among people of all ages were attributed to the use of e-cigarettes and vaping products, particularly those containing vitamin E acetate (VEA).
'While the association between vaping and popcorn lung is a concern that has received widespread media attention, it remains less common in clinical practice,' said Dr. Mendez.
'Some flavored e-cigarettes have been found to contain diacetyl; however, there have been very few confirmed cases of bronchiolitis obliterans directly attributable to vaping. What we are seeing more frequently are other vaping-related lung injuries, such as EVALI, which can mimic some of the same respiratory symptoms but represents a different disease process. There is some indication that one of the primary causative agents in EVALI is VEA, although there may be other causes. Continued research and regulation are needed to fully understand the long-term pulmonary risks associated with vaping.'
Costanzo said he believes there's a correlation to be concerned about between an increasing prevalence of bronchiolitis obliterans in recent years driven by the popularity of vaping products. Rose is convinced that time will prove a direct causation.
'It might not be as obvious as it was for workers who were exposed to large quantities, but chronic vaping of these chemicals could lead to substantial adverse lung health outcomes in the longer term,' she said. 'The [people] who are vaping regularly might seem fine, but if they're doing that every day for the next 10 years, we might start to see affects. Or they might have more accelerated decline in lung function without having many other symptoms.'
Case said she has already seen enough incidences to determine a link. 'For me, the evidence is there,' she said. 'When we talk about vaping-associated lung diseases, bronchiolitis obliterans is one of them.'
'But the problem of lack of clarity is that you can put anything into a vape. Because there is so much variability, it's become more difficult to pin down what can cause this by vaping. There are so many additives to the flavors,' continued Case. 'We need to talk about this as being generally harmful because you lose the weight of evidence when we try to get more specific on something that we just don't have enough information on. And as vaping has become more prevalent, it stands to reason that the people who are more susceptible to lung injury from it will experience it at a higher rate.'
Protocols for Better Awareness
Greater awareness and suspicion of 'popcorn lung' is needed in the presence of certain symptoms and occupational hazards, experts suggest.
'When a clinician sees signs of emphysema or small airways disease in never smokers, their alarms for work-related or exposure-related lung disease should go up,' said Rose.
'The most important thing is to take a careful occupational history — take the time to ask patients about what they spend their time doing. If they're working in food production or fragrance, that should trigger an understanding that there could be a risk to artificial chemicals or flavorings that can confer risk for lung disease. We're very well-conditioned to taking a careful history for those patients who smoke, but we need the same to be true for vaping now too. We also need to take into account things like hookah or other types of inhalants that may confer risk for small airway diseases.'
There's also a significant need to improve awareness of the disease among the general public, especially for those who work in high-risk settings and/or use a vape or similar device.
'The person experiencing it probably doesn't know anyone else who has been diagnosed,' said Case. 'There's not a drug being promoted to treat it. We need to promote self-advocacy and advocacy for loved ones. When our patients are experiencing these symptoms, it's an important message that they need to know. The old medical adage says, 'when you hear hoofbeats think horses, not zebras,' but this is truly one of the zebras. It's being missed.'
Case, Costanzo, and Mendez reported no relevant financial disclosures.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Astronauts launch to the space station after sidelined by Boeing's troubled Starliner
Astronauts launch to the space station after sidelined by Boeing's troubled Starliner

Yahoo

time14 minutes ago

  • Yahoo

Astronauts launch to the space station after sidelined by Boeing's troubled Starliner

CAPE CANAVERAL, Fla. (AP) — Astronauts sidelined for the past year by Boeing's Starliner trouble blasted off to the International Space Station on Friday, getting a lift from SpaceX. The U.S.-Japanese-Russian crew of four rocketed from NASA's Kennedy Space Center. They'll replace colleagues who launched to the space station in March as fill-ins for NASA's two stuck astronauts. Their SpaceX capsule should reach the orbiting lab this weekend and stay for at least six months. Zena Cardman, a biologist and polar explorer who should have launched last year, was yanked along with another NASA crewmate to make room for Starliner's star-crossed test pilots. The botched Starliner demo forced Butch Wilmore and Suni Williams to switch to SpaceX to get back from the space station more than nine months after departing on what should have been a weeklong trip. Ensuring their safe return 'meant stepping aside," Cardman said before her launch. 'Every astronaut wants to be in space. None of us want to stay on the ground, but it's not about me,' said Cardman, the flight commander. Even after launch, "things can change at the last minute, so I'll count myself very fortunate when the hatch opens' to the space station. NASA's Mike Fincke — Cardman's co-pilot — was the backup for Wilmore and Williams on Starliner, making those three still the only ones certified to fly it. Fincke and Japan's Kimiya Yui, former military officers with previous spaceflight experience, were training for Starliner's second astronaut mission. With Starliner grounded until 2026, NASA switched the two to the latest SpaceX flight. Rounding out the crew is Russia's Oleg Platonov. The former fighter pilot was pulled a few years ago from the Russian Soyuz flight lineup because of an undisclosed health issue that he said has since been resolved. On hand for the first launch attempt on Thursday, NASA's new acting administrator, Transportation Secretary Sean Duffy, met with Roscosmos director general Dmitry Bakanov, an invited guest. The two discussed future collaboration, then left town after thick clouds forced a last-minute delay. 'What we learn on these missions is what's going to get us to the moon and then from the moon to Mars, which is I think the direction that NASA has to be,' Duffy said in a NASA interview. 'There's critical real estate on the moon. We want to claim that real estate for ourselves and our partners.' To save money in light of tight budgets, NASA is looking to increase its space station stays from six months to eight months, a move already adopted by Russia's space agency. SpaceX is close to certifying its Dragon capsules for longer flights, which means the newly launched crew could be up there until April. NASA is also considering smaller crews — three astronauts launching on SpaceX instead of the typical four — to cut costs. As for Starliner, NASA is leaning toward launching the next one with cargo before flying another crew. Engineers are still investigating the thruster failures and helium leaks that bedeviled Starliner following liftoff. Time is running out as NASA looks to abandon the aging space station by 2030. An air leak on the Russian side of the station remains unresolved after years of patching. 'I am not in the least worried' about the leak, which is localized, Platonov said earlier this month. ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute's Department of Science Education and the Robert Wood Johnson Foundation. The AP is solely responsible for all content. Marcia Dunn, The Associated Press Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data

Washington Trust earns Exemplary Worksite Health Award for ninth consecutive year
Washington Trust earns Exemplary Worksite Health Award for ninth consecutive year

Yahoo

time14 minutes ago

  • Yahoo

Washington Trust earns Exemplary Worksite Health Award for ninth consecutive year

WESTERLY, R.I., Aug. 1, 2025 /PRNewswire/ -- For the ninth year in a row, Washington Trust has been recognized with an Exemplary Worksite Health Award from Blue Cross & Blue Shield of Rhode Island (BCBSRI) and the Greater Providence Chamber of Commerce (the Chamber) for effective programs encouraging employee health and well-being in a meaningful way. Washington Trust has been included on the winners list for over 15 years. Washington Trust was one of nearly 50 Rhode Island businesses honored by BCBSRI and the Chamber with a Worksite Health Award at a breakfast attended by hundreds of state business leaders. The event celebrated local businesses who have demonstrated a commitment to improving Rhode Islanders' overall health through innovative wellness programs. Washington Trust was honored with an Exemplary Worksite Health Award in recognition of its enduring commitment to employee well-being and a dynamic workplace culture. For more than two decades, Washington Trust has offered a comprehensive well-being program that supports physical, emotional, and financial health and includes incentives such as discounted medical premiums and access to financial planning resources. Washington Trust fosters a collaborative, growth-oriented environment, and promotes inclusivity and engagement through employee resource groups, including Pride, ¡Somos!, Unity, and Ascend. High satisfaction ratings from annual culture surveys underscore Washington Trust's success in cultivating a workplace where individuals thrive both personally and professionally. ABOUT WASHINGTON TRUST®Founded in 1800, Washington Trust is recognized as the oldest community bank in the nation, the largest state-chartered bank headquartered in Rhode Island and one of the Northeast's premier financial services companies. Washington Trust values its role as a community bank and is committed to helping the people, businesses, and organizations of New England improve their financial lives. The Bank offers a wide range of commercial banking, mortgage banking, personal banking and wealth management services through its offices in Rhode Island, Connecticut and Massachusetts and a full suite of convenient digital tools. Washington Trust is a member of the FDIC and an equal housing lender. Washington Trust is a subsidiary of Washington Trust Bancorp, Inc., a publicly-owned holding company which trades on NASDAQ: WASH. For more information, visit the Bank's website at or the Corporation's website at About BCBSRIBlue Cross & Blue Shield of Rhode Island ( is a non-profit, community-focused health plan established in 1939 to help Rhode Islanders finance their healthcare needs. Today, that purpose is still foundational to our work. We have a vision to improve health and well-being by leading access to high quality, affordable, and equitable care. We are an independent licensee of the Blue Cross and Blue Shield Association. Connect with us on Facebook, LinkedIn and Instagram. About the Greater Providence Chamber of CommerceThe Greater Providence Chamber of Commerce is Rhode Island's only statewide chamber. The Chamber is the hub of connections for Rhode Island businesses of all sizes, in all industries and in all sectors. For more information, visit follow us on Twitter @Provchamber, and like us on Facebook. View original content to download multimedia: SOURCE The Washington Trust Company

States sue Trump, saying he is intimidating hospitals over gender-affirming care for youth
States sue Trump, saying he is intimidating hospitals over gender-affirming care for youth

Associated Press

time17 minutes ago

  • Associated Press

States sue Trump, saying he is intimidating hospitals over gender-affirming care for youth

Seventeen Democratic officials accused President Donald Trump's administration of unlawfully intimidating health care providers into stopping gender-affirming care for transgender youth in a lawsuit filed Friday. The complaint comes after a month in which at least eight major hospitals and hospital systems — all in states where the care is allowed under state law — announced they were stopping or restricting the care. The latest announcement came Thursday from UI Health in Chicago. Trump's administration announced in July that it was sending subpoenas to providers and focusing on investigating them for fraud. It later boasted in a news release that hospitals are halting treatments. The Democratic officials say Trump's policies are an attempt to impose a nationwide ban on the treatment for people under 19 — and that's unlawful because there's no federal statute that bans providing the care to minors. The suit was filed by attorneys general from 15 states and the District of Columbia, plus the governor of Pennsylvania, in U.S. District Court in Boston. 'The federal government is running a cruel and targeted harassment campaign against providers who offer lawful, lifesaving care to children,' New York Attorney General Letitia James said in a statement. Trump and others who oppose the care say that it makes permanent changes that people who receive it could come to regret — and maintain that it's being driven by questionable science. Since 2021, 28 states with Republican-controlled legislatures have adopted policies to ban or restrict gender-affirming care for minors. In June, the U.S. Supreme Court ruled that states have a right to enforce those laws. For families with transgender children, the state laws and medical center policy changes have sparked urgent scrambles for treatment. The medical centers are responding to political and legal pressure The Center for Transyouth Health and Development at Children's Hospital Los Angeles, the biggest public provider of gender-affirming care for children in teens in the U.S., closed in July. At least seven other major hospitals and health systems have made similar announcements, including Children's National in Washington D.C., UChicago Medicine and Yale New Haven Health. Kaiser Permanente, which operates in California and several other states, said it would pause gender-affirming surgeries for those under 19 as of the end of August, but would continue hormone therapy. Connecticut Children's Medical Center cited 'an increasingly complex and evolving landscape' for winding down care. Other hospitals, including Penn State, had already made similar decisions since Trump returned to office in January. Alex Sheldon, executive director of GLMA, an organization that advocates for health care equity for LGBTQ+ people, said the health systems have pulled back the services for legal reasons, not medical ones. 'Not once has a hospital said they are ending care because it is not medically sound,' Sheldon said. Trump's administration has targeted the care in multiple ways Trump devoted a lot of attention to transgender people in his campaign last year as part of a growing pushback from conservatives as transgender people have gained visibility and acceptance on some fronts. Trump criticized gender-affirming care, transgender women in women's sports, and transgender women's use of women's facilities such as restrooms. On his inauguration day in January, Trump signed an executive order defining the sexes as only male and female for government purposes, setting the tone for a cascade of actions that affect transgender people. About a week later, Trump called to stop using federal money, including from Medicaid, for gender-affirming care for those under 19. About half of U.S. adults approve of Trump's handling of transgender issues, an AP-NORC poll found. But the American Medical Association says that gender is on a spectrum, and the group opposes policies that restrict access to gender-affirming health care. Gender-affirming care includes a range of medical and mental health services to support a person's gender identity, including when it's different from the sex they were assigned at birth. It includes counseling and treatment with medications that block puberty, and hormone therapy to produce physical changes, as well as surgery, which is rare for minors. In March, a judge paused enforcement of the ban on government spending for care. The court ruling didn't stop other federal government action In April, Attorney General Pam Bondi directed government investigators to focus on providers who continue to offer gender-affirming care for transgender youth. 'Under my leadership, the Department of Justice will bring these practices to an end,' she wrote. In May, the Department of Health and Human Services issued a report discouraging medical interventions for transgender youth and instead focusing solely on talk therapy. The report questions adolescents' capacity to consent to life-changing treatments that could result in future infertility. The administration has not said who wrote the report, which has been deeply criticized by LGBTQ+ advocates. In June, a Justice Department memo called for prioritizing civil investigations of those who provide the treatment. In July, Justice Department announced it had sent more than 20 subpoenas to doctors and clinics involved in gender-affirming care for youth, saying they were part of investigations of health care fraud, false statements and other possible wrongdoing. And in a statement last week, the White House celebrated decisions to end gender-affirming care, which it called a 'barbaric, pseudoscientific practice' Families worry about accessing care Kristen Salvatore's 15-year-old child started hormone therapy late last year at Penn State Health. Salvatore said in an interview with The Associated Press before the lawsuit was announced that it was a major factor in reduced signs of anxiety and depression. Last month, the family received official notice from the health system that it would no longer offer the hormones for patients under 19 after July 31, though talk therapy can continue. Salvatore has been struggling to find a place that's not hours away from their Mechanicsburg, Pennsylvania, home that would provide the hormones and accept Medicaid coverage. 'I'm walking around blind with no guidance, and whatever breadcrumbs I was given are to a dead-end alleyway,' she said. The family has enough testosterone stockpiled to last until January. But if they can't find a new provider by then, Salvatore's child could risk detransitioning, she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store